Using DU145 metastatic prostate cancer cells as the experimental model, it was demonstrated that inhibition of the p130Cas-CrkII pathway is crucial for the KAI1/CD82-mediated suppression of cell motility in DU145 cells [81]. Here, BCAR1 is linked to prostate carcinoma.